MAP kinase phosphatase 1 is expressed and enhanced by FK506 in surviving mamillary, but not degenerating nigral neurons following axotomy

The MAP kinase phosphatase 1 (MKP-1), a dual serine-threonine phosphatase, inactivates the MAP kinases ERK and JNK/SAPK which are involved in neuronal survival and neuronal cell death following injury and degenerative stimuli. We have studied by immunocytochemistry whether regulation of MKP-1 is par...

Full description

Saved in:
Bibliographic Details
Main Authors: Winter, Christine (Author) , Schenkel, Johannes (Author) , Zimmermann, Manfred (Author) , Herdegen, Thomas (Author)
Format: Article (Journal)
Language:English
Published: 9 September 1998
In: Brain research
Year: 1998, Volume: 801, Issue: 1, Pages: 198-205
ISSN:1872-6240
DOI:10.1016/S0006-8993(98)00601-5
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0006-8993(98)00601-5
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0006899398006015
Get full text
Author Notes:Ch. Winter, J. Schenkel, M. Zimmermann, T. Herdegen
Description
Summary:The MAP kinase phosphatase 1 (MKP-1), a dual serine-threonine phosphatase, inactivates the MAP kinases ERK and JNK/SAPK which are involved in neuronal survival and neuronal cell death following injury and degenerative stimuli. We have studied by immunocytochemistry whether regulation of MKP-1 is part of the cell-body response following nerve fiber transection. The expression of MKP-1 was investigated in axotomized neurons of the corpus mamillaris (CMm) and substantia nigra pars compacta (SNC) following transection of the mamillo-thalamic tract (MT) and the medial forebrain bundle (MFB), respectively. In contrast to the surviving CMm neurons, the vast majority of SNC neurons undergoes cell death following axotomy. MKP-1 immunoreactivity which is absent in untreated adult rats, appeared in CMm neurons 24 h following MT transection, reached a maximum after 2 days and persisted in a substantial proportion of CMm neurons until 20 days, the end of observation period. In contradistinction, MKP-1 could not be detected in the SNC neurons. MKP-1 immunoreactivity was virtually restricted to the nuclei of neurons. Subcutaneous injection of the immunosuppressant FK506 that protects axotomized SNC neurons against neuronal cell death, enhanced the expression of MKP-1 in CMm, but failed to do so in SNC neurons. The selective expression of MKP-1 in CMm is the first finding on a different regulation of components in the stress kinase signal pathway in surviving vs. degenerating axotomized neurons.
Item Description:Gesehen am 06.05.2021
Physical Description:Online Resource
ISSN:1872-6240
DOI:10.1016/S0006-8993(98)00601-5